Mayne Pharma Group Ltd. (MAYNF)
2.35
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Mayne Pharma Group Price : 2.35 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 2.35 | 2.35 | 2.35 | 2.35 | 0.000 |
| Sep 04, 2026 | 2.35 | 2.35 | 2.35 | 2.35 | 0.000 |
| Sep 03, 2026 | 2.35 | 2.35 | 2.35 | 2.35 | 0.000 |
| Sep 02, 2026 | 2.35 | 2.35 | 2.35 | 2.35 | 0.000 |
| Sep 01, 2026 | 2.37 | 2.37 | 2.35 | 2.35 | 3000.00 |
| Aug 31, 2026 | 2.37 | 2.37 | 2.37 | 2.37 | 1500.00 |
| Aug 28, 2026 | 2.30 | 2.30 | 2.30 | 2.30 | 0.000 |
| Aug 27, 2026 | 2.30 | 2.30 | 2.30 | 2.30 | 0.000 |
| Aug 26, 2026 | 2.30 | 2.30 | 2.30 | 2.30 | 0.000 |
| Aug 25, 2026 | 2.30 | 2.30 | 2.30 | 2.30 | 0.000 |
| Aug 24, 2026 | 2.30 | 2.30 | 2.30 | 2.30 | 1500.00 |
| Aug 21, 2026 | 2.29 | 2.29 | 2.29 | 2.29 | 0.000 |
| Aug 20, 2026 | 2.29 | 2.29 | 2.29 | 2.29 | 40000.00 |
| Aug 19, 2026 | 2.29 | 2.29 | 2.29 | 2.29 | 0.000 |
| Aug 18, 2026 | 2.29 | 2.29 | 2.29 | 2.29 | 0.000 |
| Aug 17, 2026 | 2.29 | 2.29 | 2.29 | 2.29 | 0.000 |
| Aug 14, 2026 | 2.29 | 2.29 | 2.29 | 2.29 | 0.000 |
| Aug 13, 2026 | 2.29 | 2.29 | 2.29 | 2.29 | 4000.00 |
| Aug 12, 2026 | 2.31 | 2.31 | 2.31 | 2.31 | 0.000 |
| Aug 11, 2026 | 2.33 | 2.33 | 2.31 | 2.31 | 3000.00 |
| Aug 10, 2026 | 2.30 | 2.30 | 2.30 | 2.30 | 0.000 |
| Aug 07, 2026 | 2.30 | 2.30 | 2.30 | 2.30 | 0.000 |
| Aug 06, 2026 | 2.30 | 2.30 | 2.30 | 2.30 | 1000.00 |
| Aug 05, 2026 | 2.28 | 2.28 | 2.28 | 2.28 | 7007.00 |
| Aug 04, 2026 | 2.28 | 2.28 | 2.28 | 2.28 | 400.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Percheron Therapeutics Ltd. | 0.0024 |
| Starpharma Holdings Ltd. | 5.80 |
| Neuren Pharmaceuticals Ltd. | 16.10 |
| Acrux Ltd. | 0.0033 |
| Zelira Therapeutics Ltd. | 0.26 |
Price Related Metrics
| PE Ratio | 15.21 |
| PS Ratio | 0.7958 |
| Price to Free Cash Flow | 23.90 |
| Earnings Yield | 6.57% |
| Market Cap | 190.93M |